Objective To compare disease course in patients with Guillain-Barré syndrome (GBS) with a poor prognosis who were treated with one or with two intravenous immunoglobulin (IVIg) courses. Methods From the International GBS Outcome Study, we selected patients whose modified Erasmus GBS Outcome Score at week 1 predicted a poor prognosis. We compared those treated with one IVIg course to those treated with two IVIg courses. The primary endpoint, the GBS disability scale at 4 weeks, was assessed with multivariable ordinal regression. Results Of 237 eligible patients, 199 patients received a single IVIg course. Twenty patients received an α early' second IVIg course (1-2 weeks after start of the first IVIg course) and 18 patients a α late' second ...
Intravenous immunoglobulin (IVIg) plays a key role in treatment of inflammatory demyelinating polyne...
textabstractGuillain-Barré syndrome (GBS) is an acute inflammatory disorder of the peripheral nervou...
OBJECTIVE: To define the current treatment practice of Guillain-Barré syndrome (GBS). METHODS: The s...
OBJECTIVE: To compare disease course in patients with Guillain-Barré syndrome (GBS) with a poor prog...
Objective: To compare disease course in patients with Guillain-Barré syndrome (GBS) with a poor prog...
OBJECTIVE: To compare disease course in patients with Guillain-Barré syndrome (GBS) with a poor prog...
One course of intravenous immunoglobulins (IVIg) of 2 g/kg is standard treatment in Guillain-Barré s...
OBJECTIVE: To compare the disease course in patients with mild Guillain-Barré syndrome (GBS) who wer...
Objective: To compare the disease course in patients with mild Guillain-Barré syndrome (GBS) who wer...
Objective: To compare the disease course in patients with mild Guillain-Barré syndrome (GBS) who wer...
Introduction Guillain-Barré syndrome (GBS) is an acute, immune-mediated polyneuropathy that often le...
Guillain-Barr, syndrome (GBS) is an acute, immune-mediated polyneuropathy that often leads to severe...
Background: Treatment with one standard dose (2 g/kg) of intravenous immunoglobulin is insufficient ...
Objective To compare the disease course in patients with mild Guillain-Barré syndrome (GBS) who were...
Objective To compare the disease course in patients with mild Guillain-Barré syndrome (GBS) who were...
Intravenous immunoglobulin (IVIg) plays a key role in treatment of inflammatory demyelinating polyne...
textabstractGuillain-Barré syndrome (GBS) is an acute inflammatory disorder of the peripheral nervou...
OBJECTIVE: To define the current treatment practice of Guillain-Barré syndrome (GBS). METHODS: The s...
OBJECTIVE: To compare disease course in patients with Guillain-Barré syndrome (GBS) with a poor prog...
Objective: To compare disease course in patients with Guillain-Barré syndrome (GBS) with a poor prog...
OBJECTIVE: To compare disease course in patients with Guillain-Barré syndrome (GBS) with a poor prog...
One course of intravenous immunoglobulins (IVIg) of 2 g/kg is standard treatment in Guillain-Barré s...
OBJECTIVE: To compare the disease course in patients with mild Guillain-Barré syndrome (GBS) who wer...
Objective: To compare the disease course in patients with mild Guillain-Barré syndrome (GBS) who wer...
Objective: To compare the disease course in patients with mild Guillain-Barré syndrome (GBS) who wer...
Introduction Guillain-Barré syndrome (GBS) is an acute, immune-mediated polyneuropathy that often le...
Guillain-Barr, syndrome (GBS) is an acute, immune-mediated polyneuropathy that often leads to severe...
Background: Treatment with one standard dose (2 g/kg) of intravenous immunoglobulin is insufficient ...
Objective To compare the disease course in patients with mild Guillain-Barré syndrome (GBS) who were...
Objective To compare the disease course in patients with mild Guillain-Barré syndrome (GBS) who were...
Intravenous immunoglobulin (IVIg) plays a key role in treatment of inflammatory demyelinating polyne...
textabstractGuillain-Barré syndrome (GBS) is an acute inflammatory disorder of the peripheral nervou...
OBJECTIVE: To define the current treatment practice of Guillain-Barré syndrome (GBS). METHODS: The s...